[Changes of depressor responses to bradykinin with preparations blocking kininase and adrenoreceptors].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001011:Aorta; D001794:Blood Pressure / Q000187:drug effects*; D001808:Blood Vessels / Q000187:drug effects; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology*; D002614:Chelating Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006439:Hemodynamics / Q000187:drug effects; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D008168:Lung / Q000201:enzymology; D001121:Lysine Carboxypeptidase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D011480:Protease Inhibitors; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002614:Chelating Agents; D011480:Protease Inhibitors; D011941:Receptors, Adrenergic; D013438:Sulfhydryl Compounds; D014662:Vasoconstrictor Agents; D007703:Peptidyl-Dipeptidase A; D001121:Lysine Carboxypeptidase; D001920:Bradykinin
Izmenenie depressornykh otvetov na bradykinin preparatami, blokiruiushchimi kininazu i adrenoretseptory